Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-22

FDA Approved: MIRENA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for MIRENA (levonorgestrel-releasing intrauterine system) from Bayer HealthCare Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirena (levonorgestrel-releasing intrauterine system)

Snippet

SUPPL AP for MIRENA (LEVONORGESTREL)